JZJ(SH:605266) Xin Lang Cai Jing·2025-09-23 02:17Core Viewpoint - The stock price of Jianzhijia has experienced a decline of 6.47% year-to-date, with significant drops in recent trading days, indicating potential challenges in the company's market performance [2]. Company Overview - Jianzhijia Pharmaceutical Chain Group Co., Ltd. is located in Kunming, Yunnan Province, established on September 27, 2004, and listed on December 1, 2020. The company specializes in the retail of health products, including pharmaceuticals, health foods, personal care items, and daily consumables [2]. - The revenue composition of Jianzhijia includes: prescription and non-prescription drugs (72.60%), with non-prescription drugs at 39.64% and prescription drugs at 32.96%. Other segments include medical devices (7.44%), convenience products (5.05%), health foods (4.84%), and personal care products (1.18%) [2]. Financial Performance - For the first half of 2025, Jianzhijia reported a revenue of 4.457 billion yuan, a year-on-year decrease of 0.64%. However, the net profit attributable to shareholders increased by 15.11% to 72.3782 million yuan [2]. - Since its A-share listing, Jianzhijia has distributed a total of 715 million yuan in dividends, with 473 million yuan distributed over the past three years [3]. Shareholder and Institutional Holdings - As of June 30, 2025, Jianzhijia had 15,100 shareholders, a decrease of 12.99% from the previous period. The average number of circulating shares per shareholder increased by 26.21% to 10,236 shares [2]. - Among the top ten circulating shareholders, Rongtong Health Industry Flexible Allocation Mixed A/B holds 7.1 million shares, a decrease of 294,800 shares from the previous period. Meanwhile, Guangfa Innovation Upgrade Mixed has entered the list as a new shareholder with 1.7029 million shares [4].